Dosage and administration
Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue. Allow to dissolve Take 15 minutes before meals.
Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue. Allow to dissolve Take 15 minutes before meals.
Adrenalinum 9C, 15C, GCSF 4C, Interferon gamma 5C.......................Immune support
Argentum nitricum 9C, Cortex cerebralis 4C, 7C....................................Relieves mild anxiety, restlessness
Black horehound 3X, Citrus decumana 3X.............................................Drainage
Glutathione 4C........................................................................................Antioxidant
Kali carbonicum 9C, Lithium carbonicum 8X..........................................Relieves mild anxiety, restlessness
Melatonin 4C, 15C, Stomach 7C............................................................Relieves mild anxiety, restlessness
Nux vomica 5C, 7C, 9C, 15, Thalamus 7C.............................................Relieves mild anxiety, restlessness
N-acetyl cysteine 4C...............................................................................Antiaging
Penicillium notatum 8X, Sporobolomyces griseus 8X.............................Immune support
Superior gastric plexus 7C......................................................................Relieves mild anxiety, restlessness
Temporarily relieves symptoms of stress, such as:
If pregnant or breast-feeding ask a health professional before use.
Keep out of reach of children
Adults and children 12 years and older 5 pellets 3 times per day
Children between 12 years and 6 years of age 3 pellets 3 times per day
Children under 6 years 1 pellet 3 times per day to be dissolved into a little water
Questions?: info@gunainc.com
tel. (484) 223-3500
Inactive ingredient: Sucrose.
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17089-067-20 | ANTI AGE STRESS | 4 g in 1 TUBE | PELLET | 4 | 3 | |
| 17089-067-20 | ANTI AGE STRESS | 2 in 1 BOX | PELLET | 2 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17089-067 | ANTI AGE STRESS (ACETYLCYSTEINE - BALLOTA FOETIDA - EPINEPHRINE - GLUTATHIONE - INTERFERON GAMMA-1B - LENOGRASTIM - LITHIUM CARBONATE - MELATONIN - PENICILLIUM GLABRUM - POTASSIUM CARBONATE - PUMMELO - RHODOTORULA RUBRA - SILVER NITRATE - STRYCHNOS NUX-VOMICA SEED - SUS SCROFA CEREBRAL CORTEX - SUS SCROFA STOMACH - SUS SCROFA SUPERIOR GASTRIC PLEXUS - SUS SCROFA THALAMUS -) PELLET [GUNA SPA] | 3 | Current NDC, Legacy NDC, 2 package rows | 20231103_ce25f3c5-20c9-4ba8-ac58-546febf142ec.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACETYLCYSTEINE | ACTIVE INGREDIENT | WYQ7N0BPYC | 1 | |
| BALLOTA FOETIDA | ACTIVE INGREDIENT | AB2CUV0R9O | 1 | |
| EPINEPHRINE | ACTIVE INGREDIENT | YKH834O4BH | 1 | |
| GLUTATHIONE | ACTIVE INGREDIENT | GAN16C9B8O | 1 | |
| INTERFERON GAMMA-1B | ACTIVE INGREDIENT | 21K6M2I7AG | 1 | |
| LENOGRASTIM | ACTIVE INGREDIENT | 6WS4C399GB | 1 | |
| LITHIUM CARBONATE | ACTIVE INGREDIENT | 2BMD2GNA4V | 1 | |
| MELATONIN | ACTIVE INGREDIENT | JL5DK93RCL | 1 | |
| PENICILLIUM GLABRUM | ACTIVE INGREDIENT | 2IN23YUE0I | 1 | |
| POTASSIUM CARBONATE | ACTIVE INGREDIENT | BQN1B9B9HA | 1 | |
| PUMMELO | ACTIVE INGREDIENT | ET1TN5W71X | 1 | |
| RHODOTORULA RUBRA | ACTIVE INGREDIENT | 15W81V867R | 1 | |
| SILVER NITRATE | ACTIVE INGREDIENT | 95IT3W8JZE | 1 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE INGREDIENT | 269XH13919 | 1 | |
| SUS SCROFA CEREBRAL CORTEX | ACTIVE INGREDIENT | 538Q433GB7 | 1 | |
| SUS SCROFA STOMACH | ACTIVE INGREDIENT | T0920P9Z9A | 1 | |
| SUS SCROFA SUPERIOR GASTRIC PLEXUS | ACTIVE INGREDIENT | F4679CEE8H | 1 | |
| SUS SCROFA THALAMUS | ACTIVE INGREDIENT | 3D6Q7UV74J | 1 | |
| ACETYLCYSTEINE | ACTIVE MOIETY | WYQ7N0BPYC | 1 | |
| BALLOTA FOETIDA | ACTIVE MOIETY | AB2CUV0R9O | 1 | |
| CARBONATE ION | ACTIVE MOIETY | 7UJQ5OPE7D | 1 | |
| EPINEPHRINE | ACTIVE MOIETY | YKH834O4BH | 1 | |
| GLUTATHIONE | ACTIVE MOIETY | GAN16C9B8O | 1 | |
| INTERFERON GAMMA-1B | ACTIVE MOIETY | 21K6M2I7AG | 1 | |
| LENOGRASTIM | ACTIVE MOIETY | 6WS4C399GB | 1 | |
| MELATONIN | ACTIVE MOIETY | JL5DK93RCL | 1 | |
| PENICILLIUM GLABRUM | ACTIVE MOIETY | 2IN23YUE0I | 1 | |
| PUMMELO | ACTIVE MOIETY | ET1TN5W71X | 1 | |
| RHODOTORULA RUBRA | ACTIVE MOIETY | 15W81V867R | 1 | |
| SILVER CATION | ACTIVE MOIETY | 57N7B0K90A | 1 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE MOIETY | 269XH13919 | 1 | |
| SUS SCROFA CEREBRAL CORTEX | ACTIVE MOIETY | 538Q433GB7 | 1 | |
| SUS SCROFA STOMACH | ACTIVE MOIETY | T0920P9Z9A | 1 | |
| SUS SCROFA SUPERIOR GASTRIC PLEXUS | ACTIVE MOIETY | F4679CEE8H | 1 | |
| SUS SCROFA THALAMUS | ACTIVE MOIETY | 3D6Q7UV74J | 1 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 17089-067 | 17089-067-20 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MELATONIN | JL5DK93RCL | ACTIB |
| ACETYLCYSTEINE | WYQ7N0BPYC | ACTIB |
| STRYCHNOS NUX-VOMICA SEED | 269XH13919 | ACTIB |
| PENICILLIUM GLABRUM | 2IN23YUE0I | ACTIB |
| RHODOTORULA RUBRA | 15W81V867R | ACTIB |
| SUS SCROFA STOMACH | T0920P9Z9A | ACTIB |
| SUS SCROFA SUPERIOR GASTRIC PLEXUS | F4679CEE8H | ACTIB |
| SUS SCROFA THALAMUS | 3D6Q7UV74J | ACTIB |
| SUCROSE | C151H8M554 | IACT |
| EPINEPHRINE | YKH834O4BH | ACTIB |
| SILVER NITRATE | 95IT3W8JZE | ACTIB |
| BALLOTA FOETIDA | AB2CUV0R9O | ACTIB |
| PUMMELO | ET1TN5W71X | ACTIB |
| SUS SCROFA CEREBRAL CORTEX | 538Q433GB7 | ACTIB |
| POTASSIUM CARBONATE | BQN1B9B9HA | ACTIB |
| LENOGRASTIM | 6WS4C399GB | ACTIB |
| GLUTATHIONE | GAN16C9B8O | ACTIB |
| INTERFERON GAMMA-1B | 21K6M2I7AG | ACTIB |
| LITHIUM CARBONATE | 2BMD2GNA4V | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ANTI AGE STRESS | ACETYLCYSTEINE - BALLOTA FOETIDA - EPINEPHRINE - GLUTATHIONE - INTERFERON GAMMA-1B - LENOGRASTIM - LITHIUM CARBONATE - MELATONIN - PENICILLIUM GLABRUM - POTASSIUM CARBONATE - PUMMELO - RHODOTORULA RUBRA - SILVER NITRATE - STRYCHNOS NUX-VOMICA SEED - SUS SCROFA CEREBRAL CORTEX - SUS SCROFA STOMACH - SUS SCROFA SUPERIOR GASTRIC PLEXUS - SUS SCROFA THALAMUS - | Guna spa | ce25f3c5-20c9-4ba8-ac58-546febf142ec | 2023-11-02 | Warnings | 17089-067-20 17089-067 17089006720 09280a09-14fa-dd5a-e063-6394a90a3eb0 ce25f3c5-20c9-4ba8-ac58-546febf142ec |
Adverse event summaries are temporarily unavailable. Other product information remains available.